Literature DB >> 31145517

Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.

Rizka O A Jariah1, Mohamad S Hakim2.   

Abstract

Phages and bacteria are known to undergo dynamic and co-evolutionary arms race interactions in order to survive. Recent advances from in vitro and in vivo studies have improved our understanding of the complex interactions between phages, bacteria, and the human immune system. This insight is essential for the development of phage therapy to battle the growing problems of antibiotic resistance. It is also pivotal to prevent the development of phage-resistance during the implementation of phage therapy in the clinic. In this review, we discuss recent progress of the interactions between phages, bacteria, and the human immune system and its clinical application for phage therapy. Proper phage therapy design will ideally produce large burst sizes, short latent periods, broad host ranges, and a low tendency to select resistance.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bacteria; evolution; immune system; phage therapy; phages

Mesh:

Year:  2019        PMID: 31145517     DOI: 10.1002/rmv.2055

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  7 in total

Review 1.  Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

Authors:  Sabrina Royer; Aléxia Pinheiro Morais; Deivid William da Fonseca Batistão
Journal:  Arch Microbiol       Date:  2021-01-20       Impact factor: 2.552

2.  Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.

Authors:  Tatsuma Kishimoto; Waka Ishida; Ken Fukuda; Isana Nakajima; Takashi Suzuki; Jumpei Uchiyama; Shigenobu Matsuzaki; Daisuke Todokoro; Masanori Daibata; Atsuki Fukushima
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Circulation of Fluorescently Labelled Phage in a Murine Model.

Authors:  Zuzanna Kaźmierczak; Joanna Majewska; Magdalena Milczarek; Barbara Owczarek; Krystyna Dąbrowska
Journal:  Viruses       Date:  2021-02-14       Impact factor: 5.048

Review 4.  T7 Phage as an Emerging Nanobiomaterial with Genetically Tunable Target Specificity.

Authors:  Hui Yue; Yan Li; Mingying Yang; Chuanbin Mao
Journal:  Adv Sci (Weinh)       Date:  2021-12-16       Impact factor: 16.806

5.  Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro.

Authors:  Meaghan Castledine; Daniel Padfield; Pawel Sierocinski; Jesica Soria Pascual; Adam Hughes; Lotta Mäkinen; Ville-Petri Friman; Jean-Paul Pirnay; Maya Merabishvili; Daniel de Vos; Angus Buckling
Journal:  Elife       Date:  2022-02-21       Impact factor: 8.140

6.  Greater Phage Genotypic Diversity Constrains Arms-Race Coevolution.

Authors:  Meaghan Castledine; Pawel Sierocinski; Mhairi Inglis; Suzanne Kay; Alex Hayward; Angus Buckling; Daniel Padfield
Journal:  Front Cell Infect Microbiol       Date:  2022-03-04       Impact factor: 5.293

7.  Phage cocktail strategies for the suppression of a pathogen in a cross-feeding coculture.

Authors:  Lisa Fazzino; Jeremy Anisman; Jeremy M Chacón; William R Harcombe
Journal:  Microb Biotechnol       Date:  2020-08-19       Impact factor: 5.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.